Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC by Tan, Aaron C., Seet, Amanda O.L., Lai, Gillianne G.Y., Lim, Tse Hui, Lim, Alvin S.T., Tan, Gek San, Takano, Angela, Tai, David W.M., Tan, Tira J.Y., Lam, Justina Y.C., Ng, Matthew C.H., Tan, Wan Ling, Ang, Mei-Kim, Kanesvaran, Ravindran, Ng, Quan Sing, Jain, Amit, Rajasekaran, Tanujaa, Lim, Wan-Teck, Tan, Eng-Huat, Lim, Tony Kiat Hon, Tan, Daniel S.W.

Get full text

A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in... by Ho, Jingshan, Heong, Valerie, Peng Yong, Wei, Soo, Ross, Ean Chee, Cheng, Wong, Andrea, Sundar, Raghav, Liang Thian, Yee, Gopinathan, Anil, Yan Pang, Mei, Koe, Priscillia, Nathan Jeraj, Santhiay, Pyar Soe, Phyu, Yar Soe, Mu, Tang, Tiffany, Ng, Matthew C.H., Tai, David W.M., Tan, Tira J.Y., Xu, Hongmei, Chang, Hua, Landesman, Yosef, Shah, Jatin, Shacham, Sharon, Chin Lee, Soo, Tan, Daniel S.W., Cher Goh, Boon, Tan, David S.P.

Get full text

Novel therapeutic avenues in triple-negative breast cancer: PI3K/AKT inhibition, androgen receptor blockade, and beyond by Chan, Jack J., Tan, Tira J. Y., Dent, Rebecca A.

Get full text